Suven Pharmaceuticals Limited (SUVENPHAR) — Free Cash Flow Generation Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs255.04 Million represents 1% of operating cash flow (Rs255.04 Million). See Suven Pharmaceuticals Limited (SUVENPHAR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Suven Pharmaceuticals Limited across 7 annual periods. Explore SUVENPHAR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Free Cash Flow Generation Index for Suven Pharmaceuticals Limited. For the full company profile including market capitalisation, see Suven Pharmaceuticals Limited market capitalisation.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | Rs1.32 Billion | Rs2.88 Billion | Rs1.56 Billion | ▼ -46.3% |
| 2024 | 0.86x | Rs3.07 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +133.6% |
| 2023 | 0.37x | Rs1.65 Billion | Rs4.51 Billion | Rs2.86 Billion | ▼ -52.6% |
| 2022 | 0.77x | Rs2.55 Billion | Rs3.30 Billion | Rs751.87 Million | ▲ +8.6% |
| 2021 | 0.71x | Rs2.73 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -6.6% |
| 2020 | 0.76x | Rs3.17 Billion | Rs4.16 Billion | Rs994.15 Million | ▲ +701.1% |
| 2019 | -0.13x | Rs-63.81 Million | Rs504.05 Million | Rs567.86 Million | — |